|
||||||||||
| Dear [Doctor name], | ||||||||||
| United Therapeutics is pleased to announce the latest nebulizer model available for your patients taking Tyvaso: the TD-300 Tyvaso Inhalation System. We leveraged valuable feedback from patients and healthcare professionals to redesign the inhalation system to simplify the dosing process for your patients. | ||||||||||
|
TD-300 Tyvaso Inhalation System enhancements
The new ergonomically designed TD-300 device includes a series of features to help your patients with proper administration and inhalation of Tyvaso: |
||||||||||
|
||||||||||
| Click here to learn more about the TD-300 Tyvaso Inhalation System. | ||||||||||
| Beginning summer 2018, patients who receive a referral for Tyvaso will receive the TD-300 device. Beginning fall 2018, existing Tyvaso patients will be transitioned to the TD-300 device when they are eligible for their 2-year device replacement. Our goal is for all Tyvaso patients to be transitioned to the TD-300 device by mid-2019. | ||||||||||
| Your patient's specialty pharmacy will handle their transition to the new TD-300 device with no additional paperwork required from you or your office. | ||||||||||
| For more information, including scheduling a TD-300 device demonstration, please don’t hesitate to contact me. | ||||||||||
| Sincerely, | ||||||||||
|
[Representative name]
[Representative e-mail address] [Representative phone number] |
||||||||||
| Please see the complete Important Safety Information, Full Prescribing Information, Patient Product Information, and the TD-100 and TD-300 Tyvaso Inhalation System Instructions for Use manuals. | ||||||||||
|
For additional information about Tyvaso, visit www.tyvaso.com or call
1-877-UNITHER (1-877-864-8437). |
||||||||||
|
